CD47 and melanoma: The Fab portion of mAbs can be used to block signaling pathways which promote melanoma growth and survival, for example blocking TAM chemoattractant pathways, blocking immunoregulatory axes such as SIPRα/CD47 and inhibiting immunoregulatory MIF.